Reported time to AE onset1,2

For early identification and management of AEs, a series of follow-up appointments are recommended. Below is a table displaying the recommended follow-up schedule for patients receiving GIOTRIF® (afatinib) treatment:
aBy an oncologist or an oncology nurse on the basis of the hospital/centre organisation.
Adapted from Arriola E, et al. 2015.1
Diarrhoea typically has the earliest onset of all common AEs (2-3 days)1
Reported time to AE onset1,2
Common AEs associated with GIOTRIF® (afatinib) treatment are generally well managed with supportive care,3-6 and many of the most common AEs can potentially be managed by dose modification, without compromising efficacy.7-9 For more information on how some of the most common AEs associated with GIOTRIF® (afatinib) use can managed, explore the pages below.
AE=Adverse Event
References
Disclaimer
You're now leaving our website...
Do you want to continue?
Continue Cancel